Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections

Nephrology Dialysis Transplantation

Volumn 24, Issue 12, 2009, Pages 3763-3774

  Rabindranath, Kannaiyan S ^a   Bansal, Tarun ^b   Adams, James ^c   Das, Ruma ^d   Shail, Ranjit ^e   MacLeod, Alison M ^f   Moore, Carol ^g   Besarab, Anatole ^g  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^e ROYAL LONDON HOSPITAL   (United Kingdom)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

^g HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Antimicrobial locks; Antimicrobials; Bacteraemia; Catheter; Haemodialysis

Indexed keywords

ANTIINFECTIVE AGENT; CEFALOTIN; CEFAZOLIN; CEFOTAXIME; CHLORHEXIDINE; CITRATE TRISODIUM; GENTAMICIN; HEPARIN; MINOCYCLINE; POLYSPORIN; POVIDONE IODINE; PSEUDOMONIC ACID; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; CATHETER INFECTION; DIZZINESS; HEMODIALYSIS; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; PARESTHESIA; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PUBLICATION; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS; CATHETER-RELATED INFECTIONS; CLINICAL TRIALS AS TOPIC; HUMANS; RENAL DIALYSIS;

EID: 70449664494     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp327     Document Type: Article

References (58)

1. Pisoni RL, Young EW, Dysktra DM et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 2002; 61: 305-316
2. Rayner HC, Besarab A, Brown WW et al. Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Diseases Outcomes Quality Initiative (K-DOQI) Clinical Practice Guidelines. Am J Kidney Dis 2004; 44(Suppl 2): S22-S26
3. Dittmer ID, Sharp D, McNulty CAM et al. A prospective study of central venous haemodialysis catheter colonization and peripheral bac-teraemia. Clin Nephrol 1999; 51: 34-39
4. Taylor G, Gravel D, Johnston L et al. Prospective surveillance for primary bloodstream infections occurring in Canadian haemodialysis units. Infect Control Hosp Epidemiol 2002; 23: 716-720
5. Hannah EL, Stevenson KB, Lowder CAet al. Outbreak of haemodialy-sis vascular access site infections related to malfunctioning permanent tunneled catheters: making the case for active infection surveillance. Infect Control Hosp Epidemiol 2002; 23: 538-541
6. Saxena AK, Panhorota BR, Al-Mulhim AS. Vascular access-related infections in haemodialysis patients. Saudi J Kidney Dis Transplant 2005; 16: 46-71
7. Jean G, Charra B, Chazot C et al. Risk factor analysis for long-term tunneled dialysis catheter-related bacteraemias. Nephron 2002; 91: 399-405
8. Saeed Abdulrahman I, Al-Mueilo SH, Bokhary HA et al. A prospective study of haemodialysis access-related bacterial infections. J Infect Chemother 2002; 8: 242-246
9. Butterly DW, Schwab SJ. Dialysis access infections. Curr Opin Nephrol Hyp 2000; 209: 631-635
10. Marr KA, Sexton DJ, Conlon PJ et al. Catheter-related bacteraemia and outcome of attempted catheter salvage in patients undergoing haemodialysis. Ann Intern Med 1997; 127: 275-280
11. Kovalik EC, Raymond JR, Albers FJ et al. A clustering of epidural abscesses in chronic haemodialysis patients: risks of salvaging access catheters in cases of infection. J Am Soc Nephrol 1996; 7: 2264-2267
12. Suhocki PV, Conlon PJ Jr, Knelson MH et al. Silastic cuffed catheters for haemodialysis vascular access: thrombolytic and mechanical correction of malfunction. Am J Kidney Dis 1996; 28: 379-386
13. Engemann JJ, Friedman JY, Reed SD et al. Clinical outcomes and costs due to Staphylococcus aureus bacteraemia among patients receiving long-term haemodialysis. Infect Control Hosp Epidemiol 2005; 26: 534-539
14. Manierski C, Besarab A. Antimicrobial locks: putting the lock on catheter infections. Adv Chronic Kidney Dis 2006; 13: 245-258
15. Johnson DW, van Eps C, Mudge DW et al. Randomised, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in haemodialysis patients. J Am Soc Nephrol 2005; 16: 1456-1462
16. Mavromatidis K, Kontodemou A, Tsoulfa S et al. The impact of vancomycin administration on prevention of haemodialysis catheter-related infections. Dial Transplant 1999; 28: 727-733
17. Nori US, Manoharan A, Yee J et al. Comparison of low-dose gentam-icin with minocycline as catheter lock solutions in the prevention of catheter-related bacteraemia. Am J Kidney Dis 2006; 48: 596-605
18. Sesso R, Barbosa D, Leme IL et al. Staphylococcus aureus prophylaxis in haemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol 1998; 9: 1085-1092
19. Trerotola SO, Johnson MS, Shah H et al. Tunneled haemodialysis catheters: use of a silver-coated catheter for prevention of infection-a randomised study. Radiology 1998; 207: 491-496
20. Dogra GK, Herson H, Hutchison B et al. Prevention of tunneled haemodialysis catheter-related infections using catheter-restricted gentamicin and citrate: a randomised controlled study. J Am Soc Nephrol 2002; 12: 2133-2139
21. Weijmer MC, Van Den Dorpel MA, Van de Ven PJG et al.Randomised, clinical trial comparison of Trisodium Citrate 30% and Heparin as catheter-locking solution in haemodialysis patients. J Am Soc Nephrol 2005; 16: 2769-2777
22. Moher D, Cook JC, Eastwood S et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999; 354: 1896-1900
23. Al-Hwiesh AK, Abdul-Rahman ISA. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using van-comycin and gentamycin. Saudi J Kidney Dis Transplant 2007; 18: 239-247
24. Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 2004; 19: 1546-1551
25. Bleyer AJ, Mason L, Russell G et al. A randomised, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary haemodialysis access. Infect Control Hosp Epidemiol 2005; 26: 520-524
26. Buturovic J, Ponikvar R, Kandus A et al. Filling haemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomised study. Artif Organs 1998; 22: 945-947
27. Chatzinikolaou I, Finkel K, Hanna H et al. Antibiotic-coated haemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomised study. Am J Med 2003; 115: 352-357
28. Cooper RI, Saad TF. Prevention of bacteremia in patients with tunneled cuffed 'permanent' hemodialysis catheters using gentamicin catheter packing. J Am Soc Nephrol 1999; 10: 203A
29. Dahlberg PJ, Agger WA, Singer JR et al. Subclavian haemodialysis catheter infection: a prospective, randomised trial of an attachable silver-impregnanted cuff for prevention of catheter-related infections. Infect Control Hosp Epidemiol 1995; 18: 506-511
30. Hendrickx L, Kuypers D, Evenpoel P et al. A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters. Int J Artif Organs 2001; 24: 208-211
31. Johnson DW, MacGinley R, Kay TD et al. A randomised controlled trial of topical exit-site mupirocin application in patients with tunneled, cuffed haemodialysis catheters. Nephrol Dial Transplant 2002; 17: 1802-1807
32. Kim SH, Song KI, Chang JW et al. Prevention of uncuffed haemodial-ysis catheter-related bacteraemia using an antibiotic lock technique: a prospective, randomised clinical trial. Kidney Int 2006; 69: 161-164
33. Levin A, Mason AJ, Jindal KK et al. Prevention of haemodialysis subclavian vein catheter infectionsbytopical povidone-iodine.Kidney Int 1991; 40: 934-938
34. Lok CE, Stanley KE, Hux JEet al. Haemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 2003; 14: 169-179
35. McIntyre CW, Hulme LJ, Taal M et al. Locking of tunneled haemodialysis catheters with gentamicin and heparin. Kidney Int 2004; 66: 801-805
36. Meeus G, Kuypers DR, Claes K et al. A prospective, randomised, double-blind crossover study on the use of 5% citrate lock versus 10% citrate lock in permanent haemodialysis catheters. Blood Purificat 2005; 23: 101-105
37. Pervez A, Ahmed M, Ram S et al. Antibiotic lock technique for prevention of cuffed tunnel catheter associated bacteraemia. J Vascular Access 2002; 3: 108-113
38. Power A, Duncan N, Singh SK et al. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am J Kidney Dis 2009; 53: 1034-1041
39. Quadri KHM, Tanimu DZ, Iqbal A et al. A prospective randomised controlled trial of topical honey versus povidone iodine in the prevention of haemodialysis catheter related sepsis. J Am Soc Nephrol 1998; 9: 180A-181A
40. Saxena AK, Panhotra BR. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary haemodial-ysis catheters: a case controlled study. J Nephrol 2005; 18: 755-763
41. Saxena AK, Panhotra BR, Sundaram DS et al. Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney Int 2006; 70: 1629-1635
42. Saxena AK, Panhotra BR, Sundaram DS et al. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial. Nephrol 2006; 11: 299-305
43. Zhang P, Zhang A, Qiang H et al. A randomized controlled study on the prevention of cuff-tunneled catheter related bacteremia with gentamicin-heparin licked solution (abstract). J Am Soc Nephrol 2006; 17: 592A
44. Zhang P, Yuan J, Tan H et al. Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method. Blood Purif 2009; 27: 206-211
45. Allon M. Dialysis catheter-related bacteraemia: treatment and prophylaxis. Am J Kidney Dis 2004; 44: 779-791
46. Bleyer AJ. Use of antimicrobial catheter lock solutions to prevent catheter-related bacteraemia. Clin J Am Soc Nephrol 2007; 2: 1073-1078
47. Bergman M, Huikko S, Huovinen P et al. Finnish Study Group for Antimicrobial Resistance (FiRe Network). Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneu-moniae. Antimicrob Agents Chemother 2006; 50: 3646-3650
48. Vascular Access Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48(Suppl 1): S248-S273
49. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2002; 35: 1281-1307 (Pubitemid 35448956)
50. Renal Association (UK). Clinical guidelines-module 3a-haemodialysis. 2007. Available at: http://www.renal.org/ guidelines/module3a. html#VascularAccess (Accessed on 14 December 2007)
51. Tordoir J, Canaud B, Haage P et al. EBPG on vascular access. Nephrol Dial Transplant 2007; 22(Suppl 2): ii88-ii117
52. Pratt RJ, Pellowe CM, Wilson JA et al. EPIC 2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007; 65S: S1-S64
53. Chaiyakunapruk N, Veenstra DL, Lipsky BA et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Inter Med 2002; 136: 792-801
54. Walder B, Pittet D, Tramer M. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect Control Hosp Epidemiol 2002; 23: 748-756
55. Lu PL, Tsai JC, Chiu YW et al. Methicillin-resistant Staphylococ-cus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members. Nephrol Dial Transplant 2008; 23: 1659-1665
56. Yu VL, Goetz A, Wagener M. Staphylococcus aureus carriage and infection in patients on haemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 1986; 315: 91-96
57. Boelaert JR, De Smedt RA, De Baere YA et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol Dial Transplant 1989; 4: 278-281
58. Beathard GA. Catheter management protocol for catheter-related bac-teraemia prophylaxis. Semin Dial 2003; 16: 403-405